Bleeding rates in elderly patients on vitamin K antagonist therapy for nonvalvular atrial fibrillation.
Tay
Kok-Hoon
KH
Lip
Gregory Y H
GY
Lane
Deirdre A
DA
D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy*; D005260:Female; D016330:Frail Elderly; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D008297:Male; D012306:Risk; D019851:Thrombophilia / Q000188:drug therapy / Q000209:etiology; D014812:Vitamin K / Q000037:antagonists & inhibitors*; D014859:Warfarin / Q000009:adverse effects* / Q000627:therapeutic use
D000925:Anticoagulants; D014812:Vitamin K; D014859:Warfarin